Background: The diagnosis of viral warts is often straightforward, but their treatment is difficult and always takes a long time. Nowadays warts are usually treated with conventional methods including topical keratolytic agents, cryotherapy, electrosurgery and laser surgery. However, such treatments cause different complications, and the warts become recalcitrant. Objective: To investigate the effect of intralesional pingyangmycin injection for resistant plantar warts. Methods: From June 2006 to September 2008, we treated 66 patients with plantar warts by intralesional pingyangmycin injection after informed consent. Results: The lesions of 58 patients cleared (87.88%) after up to 4 treatments. The remaining 8 patients (12.12%) achieved partial clearance. No serious side effects were observed. Conclusion: Intralesional injection of pingyangmycin might be an effective, safe and generally well-tolerated treatment for plantar warts.

1.
Lipke MM: An armamentarium of wart treatments. Clin Med Res 2006;4:273–293.
2.
Wang YS, Tay YK, Kwok C, et al: Photodynamic therapy with 20% aminolevulinic acid for the treatment of recalcitrant viral warts in an Asian population. Int J Dermatol 2007;46:1180–1184.
3.
Munn SE, Higgins E, Marshall M, Clement M: A new method of intralesional bleomycin therapy in the treatment of recalcitrant warts. Br J Dermatol 1996;135:969–971.
4.
Lewis TG, Nydorf ED: Intralesional bleomycin for warts: a review. J Drugs Dermatol 2006;5:499–504.
5.
Zhi KQ, Wen YM, Li LJ, et al: The role of intralesional pingyangmycin in the treatment of venous malformation of facial and maxillary region. Int J Pediatr Otorhinolaryngol 2008;72:593–597.
6.
Vanhooteghem O, Richert B, de la Brassinne M: Raynaud phenomenon after treatment of verruca vulgaris of the sole with intralesional injection of bleomycin. Pediatr Dermatol 2001;18:249–251.
7.
van der Velden EM, Ijsselmuiden OE, Drost BH, et al: Dermatography with bleomycin as a new treatment for verruca vulgaris. Int J Dermatol 1997;36:145–150.
8.
Pollock B, Sheehan-Dare R: Pulsed dye laser and intralesional bleomycin for treatment of resistant viral hand warts. Lasers Surg Med 2002;30:135–140.
9.
Lichon V, Khachemoune A: Plantar warts: a focus on treatment modalities. Dermatol Nurs 2007;19:372–375.
10.
Saitta P, Krishnamurthy K, Brown LH: Bleomycin in dermatology: a review of intralesional applications. Dermatol Surg 2008;34:1299–1313.
11.
Tai KW, Chou MY, Hu CC, Yang JJ, Chang YC: Induction of apoptosis in KB cells by pingyangmycin. Oral Oncol 2000;36:242–247.
12.
Wilks DJ, Peach AH: Isolated limb infusion as a novel treatment for extensive plantar warts. Dermatology 2009;218:367–369.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.